Search results
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 1 month agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks
Zacks via Yahoo Finance· 4 months agoNovavax, Inc. NVAX reported a fourth-quarter 2023 loss of $1.44 cents per share, much wider than the...
Why Novavax Stock Hit a Fresh 52-Week Low Today
Motley Fool· 2 years agoShares of the recombinant-protein vaccine specialist Novavax (NASDAQ: NVAX) were down by a noteworthy 9.2% on heavy volume as of 9:55 a.m. ET on...
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks via Yahoo Finance· 3 weeks agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 4 days agoNovavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive...
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
Motley Fool via Yahoo Finance· 5 months agoNovavax (NASDAQ: NVAX) shares have offered investors a roller coaster ride over the past few years....
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) reports better-than-expected Q2 earnings results, as earnings and revenues beat...
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However,...
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Why Novavax (NVAX) Stock Was Down 13% on Thursday
Zacks via Yahoo Finance· 2 years agoShares of Novavax, Inc. NVAX dropped 13.3% on Sep 22 after analysts at JP Morgan recently downgraded the stock’s recommendation from Neutral to...